Position in RVTY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,691,495
+$3,378,993 QoQ
Shares Held
33,179
+927.2% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#127
of 542 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVTY Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Qsemble Capital Management, LP holds $15,729,397 across 8 Diagnostics & Research names. RVTY ranks #2 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
23,646 | $4,504,090 | |
| 2 | RVTY |
Revvity, Inc.
This page
|
33,179 | $3,691,495 | |
| 3 | A |
Agilent Technologies, Inc.
|
23,610 | $3,136,116 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
2,460 | $1,233,345 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
5,909 | $1,141,736 | |
| 6 | WAT |
Waters Corp /De/
|
2,520 | $945,100 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
1,574 | $828,616 | |
| 8 | GH |
Guardant Health, Inc.
|
1,659 | $248,899 |
All Filings in RVTY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,691,495 | 33,179 | Shares | Sole | 2026-08-03 | |
| 2025-12-31 | $312,502 | 3,230 | Shares | Sole | 2026-02-05 | |
| 2025-06-30 | $423,053 | 4,374 | Shares | Sole | 2025-08-11 | |
| 2024-06-30 | $958,105 | 9,137 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $843,045 | 8,029 | Shares | Sole | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||